VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | The future of MPN treatment: exciting agents and targets being investigated

In this video, Srdan Verstovsek, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights some exciting novel agents and targets being investigated for the treatment of myeloproliferative neoplasms (MPNs), drawing focus on the potential of calreticulin-targeted agents. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter